Jeffrey B. Mirviss - Dec 3, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Dec 3, 2023
Transactions value $
-$16,617
Form type
4
Date filed
12/4/2023, 05:42 PM
Previous filing
Nov 9, 2023
Next filing
Dec 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +649 +1.15% $0.00 57.2K Dec 3, 2023 Direct F1
transaction BSX Common Stock Tax liability -$16.6K -296 -0.52% $56.14 56.9K Dec 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Deferred Stock Units Options Exercise $0 -649 -100% $0.00* 0 Dec 3, 2023 Common Stock 649 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 3, 2019, the first anniversary of the date of grant.